Boston Scientific Corp (BSX) gets rating Downgrade from Erste Group

Anna Perez

In a filing, Boston Scientific Corp revealed its Officer ARTHUR C BUTCHER acquired Company’s shares for reported $1.76 million on Dec 01 ’25. In the deal valued at $101.55 per share,17,313 shares were bought.

Then, Zane Ellen M sold 12,891 shares, generating $1,266,978 in total proceeds. Upon selling the shares at $98.28, the Director now owns 24,134 shares.

Before that, Fitzgerald Joseph Michael sold 50,000 shares. Boston Scientific Corp shares valued at $4,973,338 were divested by the EVP & Group Pres, Cardiology at a price of $99.47 per share. As a result of the transaction, Fitzgerald Joseph Michael now holds 178,342 shares, worth roughly $18.01 million.

Erste Group downgraded its Boston Scientific Corp [BSX] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in early September from “a Perform” to “an Outperform”. Leerink Partners began covering BSX with “an Outperform” recommendation on June 16, 2025. Needham revised its rating on April 16, 2025. It rated BSX as “a Buy” which previously was an “a Hold”.

Price Performance Review of BSX

On Monday, Boston Scientific Corp [NYSE:BSX] saw its stock fall -0.56% to $101.01. Over the last five days, the stock has gained 4.26%. Boston Scientific Corp shares have risen nearly 11.97% since the year began. Nevertheless, the stocks have risen 13.09% over the past one year. While a 52-week high of $109.50 was reached on 09/09/25, a 52-week low of $85.98 was recorded on 04/07/25.

Levels Of Support And Resistance For BSX Stock

The 24-hour chart illustrates a support level at 100.62, which if violated will result in even more drops to 100.24. On the upside, there is a resistance level at 101.65. A further resistance level may holdings at 102.30.

How much short interest is there in Boston Scientific Corp?

A steep rise in short interest was recorded in Boston Scientific Corp stocks on 2025-11-14, growing by 1.44 million shares to a total of 21.08 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 19.63 million shares. There was a rise of 6.84%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.